CellaVision AB (CLVSF)

14.00 0.00 (0.00%) USD  |  OTCM  |  Oct 20, 16:00
More

CellaVision Research and Development Expense (TTM) : 11.77M for June 30, 2026

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 11.77M
March 31, 2026 10.91M
December 31, 2025 9.965M
September 30, 2025 9.514M
June 30, 2025 9.024M
March 31, 2025 8.578M
December 31, 2024 8.283M
September 30, 2024 8.198M
June 30, 2024 7.828M
March 31, 2024 7.926M
December 31, 2023 7.847M
September 30, 2023 7.844M
June 30, 2023 8.594M
March 31, 2023 8.709M
December 31, 2022 8.725M
September 30, 2022 8.795M
June 30, 2022 7.879M
March 31, 2022 7.597M
December 31, 2021 7.484M
September 30, 2021 7.431M
June 30, 2021 6.931M
March 31, 2021 6.468M
December 31, 2020 6.167M
September 30, 2020 5.977M
June 30, 2020 6.140M
Date Value
March 31, 2020 6.266M
December 31, 2019 5.952M
September 30, 2019 5.655M
June 30, 2019 5.220M
March 31, 2019 4.774M
December 31, 2018 4.490M
September 30, 2018 3.888M
June 30, 2018 3.580M
March 31, 2018 3.288M
December 31, 2017 3.141M
September 30, 2017 3.256M
June 30, 2017 3.217M
March 31, 2017 3.423M
December 31, 2016 3.418M
September 30, 2016 3.448M
June 30, 2016 3.269M
March 31, 2016 3.288M
December 31, 2015 3.215M
September 30, 2015 3.567M
June 30, 2015 3.653M
March 31, 2015 3.365M
December 31, 2014 3.267M
September 30, 2014 2.865M
June 30, 2014 2.531M
March 31, 2014 2.735M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
ALR Technologies SG Ltd. --
Carasent AB --
PHC Holdings Corp. --
SyntheticMR AB --
HealthStream, Inc. 54.05M